Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2021 Nov 5;14(11):1127.
doi: 10.3390/ph14111127.

Diversity-Oriented Synthesis: Amino Acetophenones as Building Blocks for the Synthesis of Natural Product Analogs

Affiliations
Review

Diversity-Oriented Synthesis: Amino Acetophenones as Building Blocks for the Synthesis of Natural Product Analogs

Mathias Eymery et al. Pharmaceuticals (Basel). .

Abstract

Diversity-Oriented Synthesis (DOS) represents a strategy to obtain molecule libraries with diverse structural features starting from one common compound in limited steps of synthesis. During the last two decades, DOS has become an unmissable strategy in organic synthesis and is fully integrated in various drug discovery processes. On the other hand, natural products with multiple relevant pharmacological properties have been extensively investigated as scaffolds for ligand-based drug design. In this article, we report the amino dimethoxyacetophenones that can be easily synthesized and scaled up from the commercially available 3,5-dimethoxyaniline as valuable starting blocks for the DOS of natural product analogs. More focus is placed on the synthesis of analogs of flavones, coumarins, azocanes, chalcones, and aurones, which are frequently studied as lead compounds in drug discovery.

Keywords: Diversity-Oriented Synthesis; amino acetophenones; aurones; azocanes; coumarins; flavones; natural products; quinolones.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

Figures

Figure 1
Figure 1
Chemical structures reported in this review. (A) General structures of the targeted natural products; (B) Structures of the starting blocks and natural product analogs prepared.
Scheme 1
Scheme 1
Synthesis of the starting blocks.
Scheme 2
Scheme 2
Synthesis of 5- and 7-aminoflavones.
Scheme 3
Scheme 3
Synthesis of 2-aryl-4-quinolones starting from aminodimethoxyacetophenones.
Scheme 4
Scheme 4
Access to chemical diversity through the alkylation of 4-quinolones.
Figure 2
Figure 2
Structural analogy between 3-phenylcoumarin and 3-phenyl-2-quinolone and the structure of a natural coumarin.
Scheme 5
Scheme 5
Synthesis of 3-aryl-2-quinolones.
Scheme 6
Scheme 6
Synthesis of epoxychalcones.
Scheme 7
Scheme 7
Synthesis of azaaurones.
Figure 3
Figure 3
Naturally occurring compounds containing the azocane ring.
Scheme 8
Scheme 8
Synthesis of highly functionalized azocanes.
Scheme 9
Scheme 9
Mechanism of formation of the benzoazocane 29.

References

    1. International Human Genome Sequencing Consortium Initial sequencing and analysis of the human genome. Nature. 2001;409:860–921. doi: 10.1038/35057062. - DOI - PubMed
    1. Jones L.H., Bunnage M.E. Applications of chemogenomic library screening in drug discovery. Nat. Rev. Drug Discov. 2017;16:285–296. doi: 10.1038/nrd.2016.244. - DOI - PubMed
    1. Schreiber S.L. Target-oriented and diversity-oriented organic synthesis in drug discovery. Science. 2000;287:1964–1969. doi: 10.1126/science.287.5460.1964. - DOI - PubMed
    1. Galloway W.R.J.D., Isidro-Llobet A., Spring D.R. Diversity-oriented synthesis as a tool for the discovery of novel biologically active small molecules. Nat. Commun. 2010;1:80. doi: 10.1038/ncomms1081. - DOI - PubMed
    1. Kidd S.L., Osberger T.J., Mateu N., Sore H.F., Spring D.R. Recent applications of diversity-oriented synthesis toward novel, 3-dimensional fragment collections. Front. Chem. 2018;6:460. doi: 10.3389/fchem.2018.00460. - DOI - PMC - PubMed

LinkOut - more resources